Bassim Jaffa Al Bahrani

Learn More
BACKGROUND Breast cancer (BC) is one of the most common malignancies and a foremost health issue throughout world. BC accounted for 23.1% of cancer cases diagnosed in Oman in 2009. BC is a heterogeneous disease, and immuno-histochemical (IHC) markers are used to further classify it into distinct subtypes, which are biologically discrete and display(More)
Primary central nervous system lymphoma (PCNSL) is a rare disease with a poor prognosis. It usually remains confined to central nervous system (CNS). Reports of metastases outside of the CNS are rare. We report a patient with well-documented PCNSL who responded to treatment, but subsequently developed a histologically confirmed subcutaneous metastasis to(More)
OBJECTIVE To evaluate attitude towards using systemic chemotherapy near the end of life for cancer patients. METHODS This retrospective study comprised data of all patients who died with cancer at the Medical Oncology Department of the National Oncology Centre, Muscat, Oman, from January 2009 to December 2011. The records were retrieved from the(More)
BACKGROUND Cisplatin remains a principal chemotherapy agent in the treatment of many solid tumours. However because of its nephrotoxicity, inpatient hydration schedules have been utilized to ensure safe administration. In May 1995, due to significant load on in-patient bed availability, the Medical Oncology Department of the Cancer Therapy Centre, Liverpool(More)
e18546 Background: The use of rituximab is ever increasing in terms of labelled indications, off label usage, and increasing number of eligible patients. Its administration can cause hypersensitivity, angioedema, pulmonary infiltrates, cardiac events or respiratory distress syndrome. A usual recommended schedule and regular administration over 3- 4 hours(More)
UNLABELLED Serum tumor marker (STM) estimation is often used in clinical practice in monitoring response to treatment and as a predictor of treatment failure and relapse. However, there are pitfalls in interpretation, particularly in the immediate post treatment period, when a rise in titre could be observed, the phenomenon being termed as "flare". A(More)
219 Background: Breast cancer is the commonest malignancy and major health issue globally. There is initial evidence and high possibility of molecular differences across the ethnic and geographic groups; responsible for variation in presentation, responses to treatment, and outcome. METHODS Breast cancer data from 2006 to 2010 at National Cancer Center,(More)
Metastatic breast cancer is one of most common cause of death in women worldwide. The estimated incidence of breast cancer to be metastatic at diagnosis is 6%, with a five year survival rate of about 21%. There are three types of breast cancer recurrence: local, regional and distant metastasis mainly to the lung, liver, bone or brain. Review of literature(More)